US 12,083,103 B2
Tacrolimus for improved treatment of transplant patientsGeneral
US 12,083,103 B2
Tacrolimus for improved treatment of transplant patients
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Micah Paul Young
Art Unit:
1618 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
Agent:
Inventors:
Robert D Gordon
Assignee:
Priority:
--
Filed:
08/04/21
Granted:
09/10/24
Expiration:
05/30/28
Cooperative Patent Classification (CPC)
A61A61K2300/00A61P1/00A61K